AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Digestive System Neuroendocrine Tumor

Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009n/a1 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: Pancreatic elastase-1 in blood serum An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: 68Ga-SorB PET/CT Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention NCT07649681NA6 sites๐Ÿ“ Augsburg๐Ÿ“ Erlangen๐Ÿ“ Mรผnchen Wuerzburg University Hospital ยท Tests: Gustabor server, Standard Recommendations Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours NCT06121622n/a1 site๐Ÿ“ Milan IRCCS San Raffaele Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site๐Ÿ“ Portland OHSU Knight Cancer Institute ยท Tests: Biospecimen Collection, Immune Checkpoint Inhibitor A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680Phase 258 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Bristol-Myers Squibb ยท Tests: BMS-986504, Daraxonrasib, Nivolumab + Relatlimab FDC, Temozolomide, Pumitamig Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors NCT04074135Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: 68-Gallium DOTATATE Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) NCT06141369NA1 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: individualized mRNA neoantigen vaccine (mRNA-0523-L001) A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites๐Ÿ“ New York๐Ÿ“ Huntersville๐Ÿ“ San Antonio Arvinas Inc. ยท Tests: ARV-6723, Pembrolizumab, SOC Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Avapritinib DCEUS to Assess Treatment Response to PRRT in GEP-NET NCT07319416NA1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Vuebox An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Zhengzhou๐Ÿ“ Hangzhou Beijing Tide Pharmaceutical Co., Ltd ยท Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer NCT06636435Phase 15 sites๐Ÿ“ Kashiwa๐Ÿ“ Yokohama๐Ÿ“ Niigata Chiome Bioscience Inc. ยท Tests: CBA-1205 Part 1, CBA-1205 Part 2, CBA-1205 Part 3, CBA-1205 Part 4, CBA-1205 Part 5 Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer NCT02174549Phase 1, Phase 22 sites๐Ÿ“ Palo Alto๐Ÿ“ Philadelphia Teclison Ltd. ยท Tests: Tirapazamine, Conventional Transarterial Embolization (TAE) IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites๐Ÿ“ St Louis๐Ÿ“ Houston๐Ÿ“ San Antonio ViroMissile, Inc. ยท Tests: IDOV-Immune (oncolytic vaccinia virus) A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors NCT07376707Phase 11 site๐Ÿ“ Shanghai Hefei TG ImmunoPharma Co., Ltd. ยท Tests: TGI-5 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours NCT06155318n/a1 site๐Ÿ“ Milan IRCCS San Raffaele ยท Tests: 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT05379985Phase 1, Phase 221 sites๐Ÿ“ Orange๐Ÿ“ Santa Monica๐Ÿ“ Tampa Revolution Medicines, Inc. ยท Tests: RMC-6236 RAPA-201 Therapy of Solid Tumors NCT05144698Phase 1, Phase 21 site๐Ÿ“ Hackensack Rapa Therapeutics LLC ยท Tests: RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior to RAPA-201 Therapy, Pembrolizumab (PD-1 Blocking Antibody) A Study of IBI363 in Subjects with Advanced Solid Malignancies NCT06281678Phase 29 sites๐Ÿ“ San Francisco๐Ÿ“ Ocala๐Ÿ“ Plantation Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI363 Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors NCT06016855Phase 41 site๐Ÿ“ Nashville Vanderbilt-Ingram Cancer Center ยท Tests: Tumor Debulking, Lutetium Lu 177 Dotatate, Computed Tomography, Magnetic Resonance Imaging, Copper Cu 64 Dotatate Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2ฮฑ Related Genetic Alterations (MK-6482-015) NCT04924075Phase 284 sites๐Ÿ“ Los Angeles๐Ÿ“ Chicago๐Ÿ“ Warrenville Merck Sharp & Dohme LLC ยท Tests: Belzutifan Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors NCT06663072Phase 11 site๐Ÿ“ Chicago University of Chicago ยท Tests: Fulvestrant, 177Lu-DOTATATE 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: [18F]FAPI-74, [18F]FDG Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring NCT05500391Phase 23 sites๐Ÿ“ Amiens๐Ÿ“ Caen๐Ÿ“ Lille Centre Oscar Lambret ยท Tests: Oncological Follow-up Natural History of Familial Carcinoid Tumor NCT00646022n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ ยท Tests: [18F]-DOPA Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms NCT05746182n/a3 sites๐Ÿ“ Los Angeles๐Ÿ“ San Diego๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Hereditary Cancer Panel Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites๐Ÿ“ Anderlecht๐Ÿ“ Ghent๐Ÿ“ Wilrijk European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Stereotactic body radiotherapy, Palliative RT
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy